Wednesday , 21 October 2020

Nanocarrier Based Approaches for the Treatment of Psoriasis: Opportunities and Challenges

Deepa Lashkari*
Amity University Jaipur Campus SP-1, Kant Kalwar, RIICO Industrial Area, NH-11C, Jaipur, Rajasthan

Psoriasis is a chronic, incurable, autoimmune skin disorder characterized by significant negative physical and emotional collisions as constant relapsing inflammatory and proliferative disease that influence roughly around 3.6% of the US population. The etiopathogenesis of Psoriasis is not known fully but the novel therapies are developed which not only provide better therapeutic effect, good physical stability, high entrapment of efficiency of lipophilic drugs as well as for hydrophilic drugs, low drug dosing. Nowadays these novel therapies provide successful depletion of Psoriatic skin in case of moderate to severe Psoriatic patients but it is not developed to cure the disease permanently and these novel therapies provide a new challenge and provide low-cost efficacy of drugs, good bioavailability for the treatment of Psoriasis.
Keywords: Psoriasis, novel drug delivery system, etiopathogenesis, treatment approaches, targeting sites.

Scroll To Top